In vitro activity of BMY-28100 against common isolates from pediatric infections.
AUTOR(ES)
Scribner, R K
RESUMO
The antibacterial activity of BMY-28100, a new oral cephalosporin, was measured against 300 bacterial isolates from pediatric infections by standard agar dilution methodology. The effect of inoculum size on activity was also assessed. BMY-28100 was more active than cephalexin or cefaclor against all bacterial species tested.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=174793Documentos Relacionados
- In vitro activity of BMY-28142 against pediatric pathogens, including isolates from cystic fibrosis sputum.
- In vitro activity of BMY-28100, a new oral cephalosporin.
- In vitro activity of new beta-lactam antibiotics and other antimicrobial drugs against anaerobic isolates from obstetric and gynecological infections.
- Comparative antibacterial activity of a new oral cephalosporin, BMY-28100.
- In vitro antimicrobial activity of aztreonam alone and in combination against bacterial isolates from pediatric patients.
